Submission Details
| 510(k) Number | K172569 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 25, 2017 |
| Decision Date | November 22, 2017 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K172569 is an FDA 510(k) clearance for the GenePOC CDiff, a C. Difficile Toxin Gene Amplification Assay (Class II — Special Controls, product code OZN), submitted by Genepoc, Inc. (Quebec, CA). The FDA issued a Cleared decision on November 22, 2017, 89 days after receiving the submission on August 25, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3130.
| 510(k) Number | K172569 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 25, 2017 |
| Decision Date | November 22, 2017 |
| Days to Decision | 89 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | OZN — C. Difficile Toxin Gene Amplification Assay |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3130 |
| Definition | Amplification Assay For The Detection Of C. Difficile Toxin Genes From Stool Specimens Of Symptomatic Patients. |